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Abstract: The relationship between the density of the mus- 
carinic receptor in developing rat cerebral cortex and its 
coupling to phosphoinositide turnover is examined. Tissue 
slices from rats of various ages were incubated with myo- 
[2-3H]inositol, and the effect of carbamoylcholine on the re- 
lease of total inositol phosphates was determined. Binding 
of [3H]quinuclidinyl benailate was determined in the same 
tissue. Although muscarinic receptor density in day- 18 em- 
bryonic cortex was only 5% of that in the adult, the maximal 
response of stimulated phosphoinositide turnover to carba- 
moylcholine ( 1  - 10 mM) was at the adult level (i.e., three- 
fold increase). Comparison of the dependence of the turn- 
over on carbamoylcholine concentration revealed that in 
neonates, the dose-response curve was shifted to the left, 
At birth, rat brain muscarinic acetylcholine recep- 
tor (mAChR) density is very low (10% of adults), as is 
the activity of the presynaptic marker choline acetyl- 
transferase (Coyle and Yamamura, 1976; Kuhar et 
al., 1980). Activation of the mAChR in adult brain 
(Hokin and Hokin, 1955) results in the stimulation of 
the turnover of inositol phospholipids and leads to the 
formation of the second messengers inositol 1,4,5-tris- 
phosphate (IP3) and diacylglycerol (Bemdge and Ir- 
vine, 1984; Nishizuka, 1984). Little is known about 
the functional coupling of the mAChR at early stages 
in rat brain development, although muscarinic stimu- 
lation of phosphoinositide turnover has been ob- 
served in 7-day-old cerebral cortex (Reddy and Sastry, 
1979; Lee et al., 1985) and in 6-day-old hippocampus 
(Nicoletti et al., 1986). The developing CNS thus 
offers a useful model system in which to examine the 
relationship between mAChR density and the magni- 
tude of stimulated phosphoinositide turnover. This 
study was undertaken to determine at which stage of 
development mAChRs in fetal and newborn rat cere- 
giving a half-maximal effect at concentrations approxi- 
mately tenfold lower than that in the adult. In addition, the 
partial muscarinic agonists oxotremorine-2 and beth- 
anechol were both more efficacious in young rats than in 
adults. The differences could not be accounted for either by 
alterations in agonist affinity for the receptor or by the pres- 
ence of “spare” muscarinic receptors. These results indicate 
that muscarinic receptors in fetal and newborn rat cerebral 
cortex are more efficiently coupled to stimulation of phos- 
phoinositide turnover than in the adult. Key Words: Inosi- 
to1 phospholipid-Muscarinic receptors-Rat cerebral cor- 
tex development. Heacock A. M. et al. Enhanced coupling 
of neonatal muscarinic receptors in rat brain to phospho- 
inositide turnover. J. Neurochem. 48, 1904- 19 1 1 ( 1987). 
bra1 cortex are coupled to phosphoinositide turnover 
and to explore the possibility of differences in cou- 
pling characteristics during development. The results 
indicate that mAChRs of 18-day-old embryonic cere- 
bral cortex, the earliest examined, are linked to stimu- 
lated inositol lipid hydrolysis. Moreover, although few 
receptors are present in fetal and neonatal rat brain, 
they appear to be more efficiently coupled to the phos- 
phoinositide response than are adult mAChRs. A pre- 
liminary report of this study has appeared in abstract 
form (Heacock et al., 1986). 
MATERIALS AND METHODS 
Carbamoylcholine (carbachol), bethanechol, atropine, 
and arterenol (noradrenaline) were purchased from Sigma 
Chemical Co. (St. Louis, MO, U.S.A.); ibotenic acid was 
obtained from Regis Chemical Co. (Morton Grove, IL, 
U.S.A.); my0-[2-~H]inositol (1 5 Ci/mmol) was purchased 
from ARC (St. Louis, MO, U.S.A.); and ~-[~H]quinuclidi- 
nyl benzilate (QNB; 33.1 Ci/mmol) and propylbenzylcho- 
line mustard (PrBCM) were purchased from New England 
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Nuclear (Boston, MA, U.S.A.). Dowex-1 X 8 (100-200 
mesh; in the formate form) was obtained from BioRad 
(Rockville Centre, NY, U.S.A.). 
Release of labeled inositol phosphates from 
brain slices 
Wistar rats of the indicated ages were killed by decapita- 
tion, the cerebral cortex was dissected, and cross-chopped 
slices (350 X 350 pm) prepared on a McIlwain tissue chop- 
per. For the newborn rats, tissue pooled from eight to 12 
animals was used for each experiment. Adult (6-10 weeks, 
male) samples included tissue from one to two animals. A 
continuous labeling paradigm (Bemdge et al., 1982) was 
camed out essentially as previously described (Fisher and 
Bartus, 1985). This was chosen, rather than prelabeling, be- 
cause of its greater sensitivity and decreased handling of the 
fragile neonatal tissue. Tissue slices were washed five times 
for a total of 30-45 rnin in 10-20 ml of warm buffer A [ 142 
mMNaC1; 5.6 mMKC1; 2.2 mMCaC12; 3.6 mMNaHC03; 
1 mM MgC12; 5.6 mM glucose; and 30 mM N-2-hydroxy- 
ethylpiperazine-N‘-2-ethanesulfonic acid (HEPES buffer, 
pH 7.4)]. Fifty microliter aliquots of tissue slices (0.6-1.1 
mg of protein) were incubated for 120 min at 37°C in buffer 
A, which contained 3 pCi (0.4 p M )  my0-[2-~H]inositol, I5 
mM LiCI, and the indicated agonists (or buffer A for con- 
trols), in a total volume of 0.5 ml (Bemdge et al., 1982). 
Reactions were terminated by the addition of 1.5 ml ofchlo- 
roform/methanol (1  :2, by vol). The water-soluble total ino- 
sitol phosphates (IPS) were separated from rnyo-[2-’H]inosi- 
to1 by ion-exchange chromatography and quantitated as 
previously described (Fisher et al., 1984). An aliquot of the 
lower organic phase was removed to determine the incorpo- 
ration of my0-[2-~H]inositol into phospholipid. Data are ex- 
pressed as dpm [3H]IPs per lo4 dpm [’H]inositol lipids. In 
some experiments, radioactivity in individual IP species was 
determined following sequential elution of Dowex- 1 (for- 
mate form) ion-exchange columns (Berridge et ah, 1983). 
For both neonatal and adult rats, most of the radioactivity 
was in inositol 1-phosphate (IPl), as previously noted for 
guinea pig brain (Fisher and Bartus, 1985), with only 0.3- 
0.6% of the radioactivity in IP3. Prior to each experiment, 
the rny0-[2-~H]inositol substrate was passed through a sim- 
ilar column to remove possible polar contaminants. Data 
for stimulated IP release as a function of agonist concentra- 
tion were analyzed as described previously by means of a 
computer curve-fitting program (Fisher et al., 1983) that 
gives the concentration of agonist required for one-half 
maximal stimulation of IP release (EGO). Data are pre- 
sented as mean k SEM. Statistical significance was evalu- 
ated by means of the Student’s t test. 
[3H]QNB binding to brain homogenates 
Homogenates of freshly dissected cerebral cortex were 
prepared in 10 mMsodium phosphate buffer (pH 7.4) and 
100-400 pg of protein incubated in 2 ml of buffer A at 20°C 
with 1.0 nA4 L-[~H]QNB. Reactions were terminated after 
90 min by vacuum filtration through GF/B filters, and ra- 
dioactivity was quantitated as previously described (Fisher 
et al., 1983). Specific binding was calculated by subtraction 
of radioactivity bound in the presence of 10 pM atropine. 
Analysis of t3H]QNB binding to tissue homogenates and its 
competition by carbachol was performed by a computer 
curve-fitting program that generates values for concentra- 
tions of high- and low-affinity forms of mAChR, with the 
corresponding affinities KH and KL, and the percentages of 
high- and low-affinity sites (McKinney and Coyle, 1982; 
Fisher et al., 1983). The data were fitted to both a one- and 
two-site model (i.e., one or two affinity forms of the recep- 
tor) and best fit determined by a minimum sum of the 
squared residuals and a Student’s t test on the differences 
(significance at p < 0.05). The data were also examined for 
a systematic deviation from a one- or two-site model by 
nearest neighbor residual analysis (Birdsall et al., 1978). 
Protein was measured by the method of Geiger and Bess- 
man (1972). 
Receptor alkylation 
PrBCM, at a concentration of 0.2 mM, was cyclized in 10 
mM sodium phosphate buffer (pH 7.4) for 45 min at room 
temperature to form the aziridium ion (Young et al., 1972). 
Brain slices suspended in buffer A were then incubated with 
PrBCM (2 X low9 to 2 X lo-* M )  at 37°C for 15 min. Fol- 
lowing extensive washing of the slices with buffer A at 37°C 
to remove unbound PrBCM, aliquots were either homoge- 
nized for determination of QNB binding or incubated with 
my0-[2-’H]inositol, as described above, in the presence or 
absence of 1 mM carbachol. Although some recovery from 
mAChR inactivation is reported to occur (Young et al., 
I972), preliminary studies have established that the degree 
of receptor occlusion remains constant during the measure- 
ment of phosphoinositide turnover (S. K. Fisher, unpub- 
lished observations). 
RESULTS 
Comparison of mAChR density and stimulated 
IP release 
Incorporation of my0-[2-~H]inositol into inositol 
lipids and basal release of [3H]IPs increased in a linear 
or nearly linear manner during the 2-h incubation pe- 
riod (data not shown). Initial experiments revealed 
age-related differences in inositol lipid labeling and a 
concomitant decline with age of basal release of 
[3H]IPs from 3494 * 174 dpm/mg protein in the neo- 
nate to 1,668 k 123 dpm/mg protein in the adult (n 
= 4, p < 0.05; see also Nicoletti et al., 1986). Since 
basal release of [3H]IPs is proportional to the amount 
of [3H]inositol incorporated into lipids, this difference 
was no longer apparent if the basal values for unstim- 
ulated IP release were normalized to lipid labeling: 1- 
day-old cortex = 421 * 65 and adult cortex = 439 
f 112 dpm [3H]IP/104 dpm 3H-lipid (see also Table 
1). Thus, the latter method of calculation offers a 
more valid means of comparison and was used for all 
of the data presented here. Cortical tissues from 18- 
day-old embryos, newborn, and adult rats were la- 
beled with rny0-[2-~H]inositol, and the ability of car- 
bachol to  enhance release of [3H]IPs was assessed (Fig. 
1A). Tissue from the same animals was also assayed 
for [3H]QNB binding (Fig. IB). The concentration of 
carbachol necessary to achieve maximal stimulation 
of IP release vaned among the groups of animals from 
1 to 10 mA4. This stimulation was blocked (75-100%) 
by inclusion of atropine ( A& not shown). Exami- 
nation of the individual IP species revealed the pre- 
dominant species in stimulated tissue, as under basal 
conditions, was IP, , whereas only small increases (40- 
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TABLE 1. Ontogeny ofugonist-stimulated 
phosphoinositide turnover 
Radioactivity in IPS 
(dpm/ lo4 dpm 'H-lipid) 
Age Control CCh IBO NA 
1 day 244% 36 1,368 f 35 2,398 + 158 722 + 151 
7 day 259 f 11 2,834 f 588 1,742 k 333 584 + 12 
1 1  day 257 k 34 2,737 + 33 1,879 & 249 981 2 21 
Adult 270% I5 1.039+ 124 617+ 15 1,451 +81 
Slices of cerebral cortex from rats of the indicated ages were incu- 
bated with ['H]inositol in the absence (control) or presence of one 
of the following agonists: carbachol (CCh 10 mM), ibotenic acid 
(IBO; 1 a), or norepinephrine (NA; 0.1 M). After 2 h, reactions 
were terminated by the addition of 1.5 ml chloroform-methanol 
(1:2, by vol), and radioactivity in the IPS fraction and in inositol 
lipids was determined as described in Materials and Methods. Basal 
labeling of 'H-lipid (dpm/mg protein) in 1-, 7-, 1 1 -day-old and adult 
tissue was 5.7 X lo4, 4.0 X lo4, 3.7 X lo4, and 2.7 X lo4, respec- 
tively. Only minimal alterations in lipid labeling were observed on 
addition of agonist. Values shown are means (+SEM) of triplicate 
samples from one of two similar experiments. 
50%) in [3H]lP3 release in response to carbachol were 
observed. 
Although mAChR density showed a progressive in- 
crease during development, reaching adult levels by 6 
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FIG. 1. Developmental changes in carbachol-stimulated [3H]IP 
release (A) and mAChR concentration (B) in rat cerebral cortex. 
A: Tissue slices from 18-day-old embryos (18E), newborn (1-11 
days postnatal), and adult rats were incubated in triplicate with 
3 pCi [3H]inositol and 15 mM LiCl in the presence of 0-10 mM 
carbachol. Reactions were terminated after 2 h, and radioactivity 
in the IP fraction and in inositol lipids was determined. Data are 
calculated as dpm [3H]IP/104 dpm 3H-lipid and are expressed as 
percent of control (XlO-'). Values at 6-1 1 days were significantly 
different from adult (p < 0.01), whereas values at 1 day were not. 
B: Binding of [3H]QNB to tissue homogenates (100-400 pg pro- 
tein) was determined by a filtration assay following incubation with 
1 nM [3H]QNB for 90 min in the presence or absence of 10 pM 
atropine. Values shown are mean % SEM (or range, for n = 2) for 
the number of experiments indicated. 
E I O O r  
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FIG. 2. Dose-response curves for stimulated release of IPS in 1- 
day-old (0) and adult (0) rat cortex. Tissue slices were incubated 
with 3 pCi my0-[2-~H]inositol in the presence of the indicated con- 
centrations of carbachol. Reactions were terminated after 120 
min, and radioactivity in the IPS fraction was determined. Data are 
expressed as a percentage of the maximum response (shown in 
Fig. 1). Each value is the mean f SEM of four individual experi- 
ments. Analysis of the data by a computer curve-fitting program 
showed a one-site interaction at both ages, although the Hill co- 
efficients were somewhat less than 1, 0.66, and 0.68 for l-day- 
old and adult tissue, respectively. 
weeks of age, an "adult" [3H]lP response to carbachol 
(three- to fourfold increase) was present in the youn- 
gest animals examined, 18-day-old embryos, a time 
when [3H]QNB binding was 4% of adult values. The 
magnitude of the carbachol response continued to in- 
crease, reaching twice that of the adult response at 6- 
11 days postnatal. Addition of carbachol led to small 
increases in inositol lipid labeling in 1 -day-old cortex 
but not in adult cortex, 125 k 4% and 100 k 4% of 
control, respectively (mean k SEM for five to eight 
separate experiments). Thus, if [3H]lP release had 
been normalized to protein content, carbachol-stimu- 
lated release in the newborn would have appeared to 
be even greater than the fourfold increase (Fig. 1) cal- 
culated by normalizing to lipid labeling. 
Dose-response for carbachol and effect of partial 
muscarinic agonists 
Comparison of the carbachol concentration curves 
for 1-day-old rat cortex and adult rat (6-10 weeks) 
cortex (Fig. 2) revealed that in the newborn animals, 
the dose-response curve was shifted to the left, with 
an EC50 (mean k SEM) of 39 k 8 pM, compared with 
the adult value of 345 k 1 15 pM(p  < 0.05). Compara- 
bly low ECso values were also found in 18-day-old em- 
bryonic and 3-day-old postnatal cortex (Fig. 3A), 
whereas the shift toward adult values appeared to be- 
gin at 6 days and be completed by 10 days postnatal. 
The changes in ECso were accompanied by alterations 
in the responses to the partial muscarinic agonists ox- 
otremorine-2 and bethanechol (Fig. 3B and C), both 
of which were more efficacious in the young rats than 
in the adults. 
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FIG. 3. Developmental changes in the ECS0 for stimulation of IP 
release by carbachol (A) and the efficacy of the partial agonists 
oxotremorine-2 (B) and bethanechol (C). A: Determination of the 
ECS0 for carbachol was carried out as described in Fig. 2 for cere- 
bral cortical tissue from rats of the indicated ages. The mean ECSo 
for 1-day-old cortex was significantly different from adult cortex 
(p < 0.05). The ECS0 was calculated by a computer curve-fitting 
program. B and C: Tissue slices from rats of the indicated ages 
were incubated with rny0-[2-~H]inositol in the presence of optimal 
concentrations of the partial muscarinic agonists oxotremorine-2 
(1 mM) or bethanechol(30 mM). Reactions were terminated after 
2 h, and radioactivity in inositol phosphates was determined. Re- 
sults are expressed as a percentage of the maximum response 
obtained with carbachol (1-10 mM). Values shown are means 
? SEM (or range, for n = 2) of the indicated number of experi- 
ments. Differences between 1 -day-old and adult cortex were not 
statistically significant for bethanechol but were for oxotremorine- 
2 (p < 0.002). (For structure of oxotremorine-2, see Fisher et al., 
1984.) 
Carbachol displacement of 13H]QNB binding 
The possibility that the low ECS0 for stimulated IP 
release by carbachol in newborns is accounted for by 
a higher affinity of the newborn mAChR for binding 
of carbachol was assessed by determining the ability 
of carbachol to displace [3H]QNB from homogenates 
of 1-day-old or adult rat cortex (Fig. 4). The percent- 
age of high-affinity sites and the KL values for the two 
groups did not differ; however, the KH for 1-day-old 
cortex appeared to be greater than that for the adult 
animals (p < 0.05). Thus, the differences in carbachol 
ECso for stimulated phosphoinositide turnover seem 
not to reflect altered agonist affinities for the mAChR. 
Effect of alkylation of neonatal mAChRs 
The apparent shift in EC50, as well as the efficacy of 
partial agonists in neonatal cortex, could be inter- 
preted to indicate the presence of “spare” receptors 
for the phosphoinositide response. This possibility 
was explored by partial alkylation of mAChRs in 1- 
day-old rat cortex with PrBCM and subsequent com- 
parison of the residual mAChR density with the abil- 
ity of carbachol to stimulate [3H]IP release (Fig. 5). 
[3H]QNB binding declined in parallel with the IP re- 
sponse ( r  = 0.9 1). Intersection with the ordinate above 
the origin might indicate that some of the mAChRs in 
the slice preparation are not accessible to carbachol 
during phosphoinositide turnover measurement, as 
has been suggested for a,-adrenergic receptors during 
the norepinephrine-stimulated inositol lipid hydroly- 
sis in rat cerebral cortex slices (Johnson and Minne- 
man, 1985). 
Comparison with other agonists 
To assess whether the magnitude of carbachol-stim- 
ulated IP release in neonatal tissue might be due to a 
general hypersensitivity of phosphoinositide turnover 
to receptor activation, the effects of norepinephrine 
and the glutamate analog, ibotenic acid, were deter- 
mined and compared with those of carbachol (Table 
1). Each displayed a unique developmental profile. In 
contrast to the equivalent stimulation of IP release in 
newborns and adults by carbachol, the efficacy of ibo- 
tenate showed a substantial decline with age, whereas 
that of norepinephrine increased. 
DISCUSSION 
Evidence is accumulating in support of a major role 
for inositol lipid breakdown in receptor-mediated 
transmembrane signaling in the CNS (Bemdge and 
Irvine, 1984; Nishizuka, 1984). mAChR-mediated 
stimulation of phosphoinositide turnover has been 
characterized both biochemically and pharmacologi- 
cally (Fisher and Agranoff, 1985; Fisher, 1986). The 
mAChR is proposed to exist in at least two intercon- 
vertible forms of high and low affinities (Birdsall et 
al., 1978). In the CNS, mAChRs appear to be tightly 
coupled to phosphoinositide turnover in that there is 
a close relationship between receptor occupancy and 
stimulated inositol lipid hydrolysis (Fisher, 1986). 
In fetal and neonatal rat brain, low levels of 
mAChR are present before cholinergic innervation 
occurs (Coyle and Yamamura, 1976; Kuhar et al., 
1980), a time when one might predict little need for 
the receptors to be functionally coupled to a trans- 
membrane signaling pathway. Contrary to this expec- 
tation, activation ofthe few receptors present in devel- 
oping rat cerebral cortex elicited as large an increase in 
phosphoinositide turnover as is observed in the adult 
(Fig. 1). Calculated as ratios of carbachol-stimulated 
IP release to mAChR density, the responses of 18-day- 
old embryonic and 1-day-old postnatal rats are, re- 
spectively, 20- and 10-fold greater than that in adult 
brain. Studies of mAChR function in embryonic 
chick heart (Orellana and Brown, 1985) and retina 
(Large et al., 1985~) have similarly revealed coupling 
of the receptors to phosphoinositide turnover prior to 
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FIG. 4. Occupancy of mAChR in 1-day-old (A) 
and adult (B) rat cerebral cortex by carbachol. 
Aliquots of homogenates of cerebral cortex 
(100-400 pg protein) were incubated with L- 
chol. The displacement of [3H]QNB binding was 
computer program that generated plots of theo- 
retical one-site (0) and two-site (0) fits. These 
are compared to the actual (A) receptor occu- 
pancy data. Similar affinity constants for 
1 -day-old and adult cortex. Carbachol binding to 
mAChR in both tissues fit the criteria for a two- 
site model (see Materials and Methods). Results 
shown are from one of four separate experi- 
ments that gave similar results. Mean values for 
K H ,  K L ,  and percent hiah-affinitv sites [+SEMI 7 6 5 4 3 2 7  6 5 4 3 2 
(-)[3H]QNB (1.0 nM in A; 1.13 nM in B) in the 
analyzed for a one- or two-site interaction by a 
1.0- 
presence of various concentrations of carba- ADULT 
g 0.8 - 
f g o,6 0.6 - 
r3H]QNB (KO), 78 and 86 pM, were obtained for 0.4- 
I I 
were 4.2 rf: 1 :3 pM. 21 2-? 19 p M ,  and 28 f 4% 
for 1 -day-old cortex, and 0.8 f 3 pM, 250 k 51 
CJM. and 24 ? 3% for adult cortex; KH for l-day- 
old cortex was significantly different from that of 
the adult cortex (p < 0.05). 
innervation. In avian heart, the ability of carbachol to 
stimulate IP release appears to decline with age (Orel- 
lana and Brown, 1985). 
A further difference in the coupling characteristics 
of neonatal and adult mAChRs was revealed by exam- 
ination of the carbachol dose-response curves (Fig. 2). 
The concentration of carbachol required to elicit a 
half-maximal phosphoinositide response was approx- 
imately tenfold lower in newborns than in adults. This 
observation might be accounted for by alterations in 
the binding of the agonist to the two affinity forms of 
the mAChR. Although there is a report that the high- 
affinity site is absent from 1-day-old rat cortex (Kuhar 
I I I I I J 
STIMULATED I P  RELEASE (% of control ) 
20 40 60 80 100 
FIG. 5. Correlation of mAChR receptor density with carbachol- 
stimulated IP release. Slices of cerebral cortex from 1 -day-old rats 
were alkylated with various concentrations of PrBCM (2 X lo-' 
to 2 X 1 O-* M), as described in Materials and Methods. Following 
washing of the tissue slices, residual [3H]QNB binding and the 
ability of carbachol(1 mM) to stimulate IP release was assessed. 
There was a significant correlation (r = 0.91, p < 0.01) between 
receptor loss and loss of stimulated IP release. Results were ob- 
tained from three separate experiments. 
-log [CARBACHOL], M 
et al., 1980), we found that 1-day-old and adult rat 
cortex contained a similar proportion of high-affinity 
sites. In addition, there was no enhancement of ago- 
nist binding affinity for either high- or low-affinity 
sites in 1 -day-old tissue. Indeed, there appears to be a 
reduced carbachol affinity for the high-affinity sites in 
1-day-old cortex (Fig. 4), a finding similar to that re- 
ported for the developing avian retina (Large et al., 
1985~). It remains possible that affinity constants ob- 
tained from tissue homogenates do not accurately re- 
flect agonist affinities of intact tissue slices, although 
comparisons of intact and homogenized N 1 E- 1 15 
neuroblastoma cells revealed no difference in musca- 
rinic agonist binding parameters (McKinney et al., 
1985). Precise comparisons between the agonist 
affinity constants and the carbachol EC50 for phos- 
phoinositide turnover are not possible, since the bind- 
ing assays were carried out at 20°C in the absence of 
Li', whereas the IP release assays were carried out at 
37°C in the presence of Li'; however, inclusion of 15 
mM LiCl in the QNB assay did not alter the binding 
characteristics of either newborn or adult cortical tis- 
sue (data not shown). Decreasing temperature report- 
edly results in small decreases in the binding constants 
for the mAChR in neuroblastoma N 1 E- 1 15 cells (Mc- 
Kinney et al., 1985). Thus, differential temperature 
effects on neonatal and adult mAChR binding charac- 
teristics cannot be ruled out, although they would not 
likely be of sufficient magnitude to affect the conclu- 
sion that differences in the affinity of the mAChR for 
carbachol do not account for differences in the EC5o 
for phosphoinositide turnover. 
The absence of marked changes in the affinity of the 
mAChR for carbachol in tissue exhibiting an en- 
hanced agonist efficacy for phosphoinositide turnover 
might indicate the presence of spare receptors, i.e., 
submaximal receptor occupancy required for maxi- 
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ma1 response. The greater efficacy of the partial mus- 
carinic agonists oxotremorine-2 and bethanechol 
(Fig. 3) is also consistent with this possibility. As ob- 
served for adult brain (Fisher and Snider, 1986), irre- 
versible inactivation of the mAChR by alkylation 
with PrBCM results in a parallel loss of receptor num- 
ber and carbachol-stimulated IP release (Fig. 5). Thus, 
in neonatal as in adult brain, there is little evidence of 
mAChR reserve for inositol lipid hydrolysis. 
The developmental profile of carbachol-stimulated 
phosphoinositide turnover in rat cerebral cortex con- 
trasts markedly with that of two other phosphoinosi- 
tide-linked agonists examined. In agreement with the 
observations of Schoepp and Rutledge (1985) and Ni- 
coletti et al. (1 986), we find that the response to nor- 
epinephrine increases during development, whereas 
that of the glutamate analog, ibotenic acid, decreases 
(Table 1). Nicoletti et al. (1986) also find a robust 
phosphoinositide response elicited by addition of car- 
bachol to 6-day-old rat hippocampus, with no sub- 
stantial change during development. Comparison 
with these other agonists may prove useful in elucidat- 
ing the mechanism of the observed enhanced cou- 
pling of fetal and neonatal mAChRs. For example, 
there is indirect evidence indicating that guanine 
nucleotide-binding regulatory proteins (G-proteins) 
play a role in receptor coupling to phosphoinositide 
turnover (Gonzales and Crews, 1985; Joseph, 1985; 
Litosch et al., 1985). G-proteins have been found to 
interact with the mAChR (Florio and Sternweiss, 
1985) and with a,-adrenergic receptors (Goodhart et 
al., 1982) and guanine nucleotides alter the binding of 
agonists to the mAChR (Ehlert et al., 1981). It has 
been suggested that a lack of such a regulatory protein 
might account for the limited coupling of a I-adrener- 
gic receptors to inositol lipid turnover in 7- and 14- 
day-old rat cortex (Schoepp and Rutledge, 1985). 
Similarly, the progressive reduction in the ability of 
glutamate and ibotenic acid to stimulate IP release in 
developing rat hippocampus (Nicoletti et al., 1986) 
may reflect the appearance of a negative or inhibitory 
coupling factor. The results described here for the 
mAChR could indicate the presence of a positive cou- 
pler early in development, which subsequently de- 
clines. Alternatively, there may be a negative coupler 
that appears later in development and serves to dimin- 
ish the signal produced by the increased numbers of 
mAChRs. Precedent for such a mechanism can be 
found in recent studies in which alterations in the cou- 
pling of heart a,-adrenergic receptors to contraction, 
on the one hand (Steinberg et al., 1985), and the cou- 
pling of heart mAChRs to adenylate cyclase inhibi- 
tion (Liang et al., 1986), on the other, could each be 
correlated with increased amounts of G-proteins. It 
may be that the greater sensitivity to muscarinic ago- 
nists in fetal and neonatal cortex constitutes a com- 
pensatory mechanism for the relatively low levels of 
acetylcholine encountered by the receptor at this stage 
of development (Coyle and Yamamura, 1976). It 
should be noted, however, that the shift to adult ECso 
values observed in the present study does not corre- 
spond closely to the developmental increase in cholin- 
ergic input to the cortex: At 10 days postnatal, the 
ECso for carbachol stimulation of inositol lipid hydro- 
lysis did not differ from the adult value, whereas corti- 
cal choline acetyltransferase activity is reportedly only 
10% of that in the adult at this time (Coyle and Yama- 
mura, 1976). 
Relevant factors that might account for the en- 
hanced coupling of the mAChR to phosphoinositide 
turnover, other than the postulated changes in regula- 
tory proteins, include possible structural alterations in 
the mAChR or in its environment that might alter its 
coupling characteristics, e.g., changes in membrane 
fluidity (Rauch and Hitzemann, 1986) or in the ana- 
tomical localization of the receptor. Differences in the 
molecular weight and isoelectric point of the mAChR 
during development have been found in embryonic 
chick retina and rat olfactory bulb (Large et al., 
1985a,b, 1986). Alternatively, the pool of inositol 
phospholipid coupled to the mAChR might be prefer- 
entially labeled with [3H]inositol in neonatal brain, 
thus giving rise to an increased specific activity of re- 
leased inositol phosphates. Data on the concentra- 
tions of the phosphoinositides in developing brain 
have recently been reviewed by Sun and Foudin 
(1985). In addition, it is likely that a common bio- 
chemical mechanism of mAChR-stimulated phos- 
phoinositide turnover is shared by neonatal and adult 
cortex, i.e., phosphodiesteratic cleavage of phosphati- 
dylinositol4,5-bisphosphate with subsequent dephos- 
phorylation of IP3 and accumulation of IPI in the 
presence of Lif (Bemdge, 1983; Bemdge et al., 1983; 
Downes and Wusteman, 1983; Fisher et al., 1984); 
however, this mechanism has not been firmly estab- 
lished in brain (Hawthorne, 1986), and given the pre- 
dominant release of IP, in both newborn and adult 
tissues, it remains possible that a secondary break- 
down of phosphatidylinositol occurs in response to in- 
creased intracellular Ca2+ (Wilson et al., 1985). 
Differences in both the affinity and efficacy with 
which muscarinic agonists enhance phosphoinositide 
turnover could well have broad significance in the un- 
derstanding of higher brain function. Such differences 
have been reported previously in both neural and 
nonneural tissues (Brown and Brown, 1984; Ek and 
Nahorski, 1986; Evans et al., 1985; Fisher et al., 1983, 
1984; Fisher and Bartus, 1985; Gil and Wolfe, 1985; 
Jacobson et al., 1985). The developing rat brain pro- 
vides a longitudinal model that lends itself particu- 
larly well to tackling the problem of how mAChR cou- 
pling to second messengers is regulated. 
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